Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece
暂无分享,去创建一个
M. Kyrtsonis | T. Vassilakopoulos | P. Papaioannou | M. Dimou | P. Panayiotidis | T. Iliakis | A. Koudouna | P. Tsaftaridis | V. Pardalis | Catherin Bitsani | M. Angelopoulou | S. Kalyva